The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Life Science

• Publication date

  2002-07-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(02)01799-XPMID 12095536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin

  2000cited by this paper
• Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.

  1999cited by this paper
• 6′,7′‐Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P‐glycoprotein

  1999cited by this paper
• Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.

  1999cited by this paper
• Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics.

  1998cited by this paper
• Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.

  1998influential reference
• The pharmacological role of P-glycoprotein in the intestinal epithelium.

  1998cited by this paper
• Role of intestinal P‐glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

  1997cited by this paper
• Design principles for orally bioavailable drugs

  1996cited by this paper
• Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.

  1996cited by this paper
• Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N‐demethylation

  1996cited by this paper
• Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.

  1995cited by this paper
• Disposition of intravenous and oral cyclosporine after administration with grapefruit juice

  1995cited by this paper
• Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy

  1995cited by this paper
• Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition.

  1995cited by this paper
• Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.

  1995cited by this paper
• Dextromethorphan metabolism in rat: interstrain differences and the fate of individually administered oxidative metabolites.

  1994cited by this paper
• [Structure and function of P-glycoprotein].

  1994cited by this paper
• Genetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics

  1994cited by this paper
• Determination of dextromethorphan and dextrorphan in urine by high-performance liquid chromatography after solid-phase extraction.

  1991cited by this paper
• Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.

  1987cited by this paper
• Applied biopharmaceutics and pharmacokinetics

  1980cited by this paper
• Genetic factors in drug therapy.

  1969cited by this paper
• Metabolism and excretion of tritiated dextromethorphan by the rat.

  1967cited by this paper

• Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans.

  2025cites this paper
• Interactions between grapefruit juice and psychotropic medications: an update of the literature and an original case series

  2024cites this paper
• The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications

  2024cites this paper
• Rhabdomyolysis secondary to a weight-loss prescription

  2024cites this paper
• P Glycoprotein Mediated Drug Interaction between Digoxin and Orange Juice- Exploratory Study by In-vitro Approach

  2023cites this paper
• Phenolic and flavonoid content and in vitro inhibitory effect of some Amazonian fruit juices on CYP3A4 activity

  2022cites this paper
• Herbal Drug Interactions

  2022cites this paper
• Potential Cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments.

  2021cites this paper
• Phytochemical and Over-The-Counter Drug Interactions: Involvement of Phase I and II Drug-Metabolizing Enzymes and Phase III Transporters

  2021cites this paper
• Effect of Vernonia Amygdalina Leaf on Cytochrome P450 2D6- and 3A4-Mediated Metabolism of Dextromethorphan in Healthy Nigerian Subjects

  2021cites this paper
• Food constituent– and herb–drug interactions in oncology: Influence of quantitative modelling on Drug labelling

  2021cites this paper
• Citrus × aurantium L. (Rutaceae)

  2020cites this paper
• Molecular docking studies of tea (Thea sinensis Linn.) polyphenols inhibition pattern with Rat P-glycoprotein

  2020cites this paper
• Mechanism-based inactivation of cytochrome P450 enzymes by natural products based on metabolic activation

  2020cites this paper
• Selected essential oils and their mechanisms for therapeutic use against public health disorders. An overview

  2020cites this paper
• Pharmacokinetics and pharmacodynamics of dextromethorphan: clinical and forensic aspects

  2020cites this paper
• Interactions between antiretroviral therapy and complementary and alternative medicine: A narrative review.

  2020cites this paper
• Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

  2020cites this paper
• Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily use.

  2019cites this paper
• Drugs and Food Interactions: Food–Drug Interactions Among the Elderly: Risk Assessment and Recommendations for Patients

  2019cites this paper
• In silico analysis of a few dietary phytochemicals as potential tumor chemo-sensitizers

  2018cites this paper
• Correlation of Pretransplant Trough Tacrolimus Level with Early Acute Rejection In Live Donor Renal Transplantation- A Prospective Study

  2018cites this paper
• Effects of tomato juice on the pharmacokinetics of CYP3A4-substrate drugs

  2017cites this paper
• Retrospective use of PBPK modelling to understand a clinical drug–drug interaction between dextromethorphan and GSK1034702

  2017cites this paper
• Effects of Lemon and Seville Orange Juices on the Pharmacokinetic Properties of Sildenafil in Healthy Subjects

  2016cites this paper
• HERB-DRUG INTERACTIONS: AN OVERVIEW OF MECHANISMS AND CLINICAL ASPECTS

  2016cites this paper
• Enzyme‐ and transporter‐mediated beverage–drug interactions: An update on fruit juices and green tea

  2015cites this paper
• Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences

  2015cites this paper
• Patterns and Perceptions of Dextromethorphan Use in Adult Members of an Online Dextromethorphan Community

  2015cites this paper
• Medicinal plant reported with adverse reactions in Cuba: potential interactions with conventional drugs

  2015cites this paper
• Absence of Furanocoumarins in Advantra Z® (Citrus aurantium, Bitter Orange) Extracts

  2014cites this paper
• An Evidence-Based Systematic Review of Bitter Orange (Citrus aurantium) by the Natural Standard Research Collaboration

  2013cites this paper
• Interactions with Drugs and Dietary Supplements Used For Weight Loss

  2013cites this paper
• DETERMINATION OF DEXTROMETHORPHAN IN PHARMACEUTICAL FORMULATIONS AVAILABLE IN DRUG MARKET OF IRAN USING HPLC METHOD

  2013cites this paper
• Drug Interactions: Reactions with Grapefruit and Related Citrus Fruits

  2012cites this paper
• Effect of Pomegranate Juice on Intestinal Transport and Pharmacokinetics of Nitrendipine in Rats

  2012cites this paper
• Influência dos sucos de frutas sobre a biodisponibilidade e meia-vida dos medicamentos

  2011cites this paper
• An overview of interactions between grapefruit juice and drugs

  2011cites this paper
• The effect of grapefruit juice on drug disposition

  2011cites this paper
• Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.

  2011cites this paper
• Synephrine: from trace concentrations to massive consumption in weight-loss.

  2011cites this paper
• Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange ( Citrus aurantium )

  2011cites this paper
• Effect of commonly consumed botanicals on drug efflux across intestinal epithelial cells and excised tissues.

  2011cites this paper
• Dynamische Modellierung und Simulation des Arzneimittelmetabolismus in humanen Leberzellen: Identifizierbarkeit, Robustheit und inter-individuelle Variabilität

  2011influential citation
• Herb–drug pharmacokinetic interactions reviewed

  2010cites this paper
• Grapefruit-Drug Interactions

  2010cites this paper
• Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.

  2010cites this paper
• Introduction to Drug Transporters

  2010cites this paper
• drug reactions

  2010cites this paper
• Role, Relevance and Regulation of PEPT1 in Peptide Intestinal Absorption.

  2010cites this paper
• [Drug interactions with grapefruit].

  2010cites this paper
• Grapefruit and Other Fruit Juices Interactions with Medicines

  2009cites this paper
• DietaryregulationofP-gp functionandexpression

  2009cites this paper
• The potential of natural products as effective treatments for allergic inflammation: implications for allergic rhinitis.

  2009cites this paper
• Dietary regulation of P-gp function and expression

  2009cites this paper
• Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites.

  2009cites this paper
• Anthocyanins and anthocyanidins are poor inhibitors of CYP2D6.

  2009cites this paper
• Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles.

  2009cites this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies.

  2008cites this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies

  2008cites this paper
• Inhibitory Effects of Fruit Juices on Cytochrome P450 2C9 Activity in Vitro

  2008cites this paper
• Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability

  2008cites this paper
• Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B

  2008cites this paper
• Validation of the use of nonnaive surgically catheterized rats for pharmacokinetics studies.

  2008cites this paper
• In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.

  2008cites this paper
• Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration.

  2008cites this paper
• Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (‐)epigallocatechin‐3‐gallate from green tea extract: a human study

  2008cites this paper
• Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs.

  2008cites this paper
• Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers

  2008cites this paper
• Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations.

  2008cites this paper
• Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoprotein.

  2008cites this paper
• Impact of the changes in P-glycoprotein activity on domperidone pharmacokinetics in rat plasma.

  2007cites this paper
• Interaction potential between cranberry juice and warfarin.

  2007cites this paper
• Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine.

  2007cites this paper
• The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs.

  2007cites this paper
• NARINGIN DOES NOT ALTER CAFFEINE PHARMACOKINETICS, ENERGY EXPENDITURE, OR CARDIOVASCULAR HAEMODYNAMICS IN HUMANS FOLLOWING CAFFEINE CONSUMPTION

  2006cites this paper
• Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.

  2006cites this paper
• Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs.

  2006cites this paper
• Analysis of Ephedra-Free Labeled Dietary Supplements Sold in the San Francisco Bay Area in 2003

  2006cites this paper
• The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.

  2006cites this paper
• Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance

  2006cites this paper
• Effects of cranberry juice on nifedipine pharmacokinetics in rats

  2006cites this paper
• Effects of citronellal, a monoterpenoid in Zanthoxyli Fructus, on the intestinal absorption of digoxin in vitro and in vivo.

  2006cites this paper
• Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans

  2006cites this paper
• Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.

  2006cites this paper
• Suco de laranja e vitamina C : efeito sobre a estabilidade genômica

  2006cites this paper
• Drug Interactions of Grapefruit and Other Citrus_What Have We Learned

  2006cites this paper
• EFFECT OF GRAPEFRUIT JUICE ON P-GLYCOPROTEIN ACTIVITY

  2006cites this paper
• Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats.

  2006cites this paper
• Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update

  2006cites this paper
• TRANSIENT INHIBITION OF CYP3A IN RATS BY STAR FRUIT JUICE

  2006cites this paper
• Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided?

  2006cites this paper
• Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.

  2006cites this paper
• Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli fructus.

  2005cites this paper
• Investigations of Liposome/Water Partitioning Using Electrokinetic Chromatography

  2005cites this paper
• Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs

  2005cites this paper
• Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects

  2005cites this paper
• EFFECTS OF POMEGRANATE JUICE ON HUMAN CYTOCHROME P450 3A (CYP3A) AND CARBAMAZEPINE PHARMACOKINETICS IN RATS

  2005cites this paper
• AND CARBAMAZEPINE PHARMACOKINETICS IN RATS

  2005cites this paper
• Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs.

  2005cites this paper